Artículos por temáticas

Fighting Parkinson's disease: The return of the mitochondria

Zambrano K, Barba D, Castillo K, Noboa L, Argueta-Zamora D, Robayo P, Arizaga E, Caicedo A, Gavilanes AWD.

Mitochondrion. 2022 May;64:34-44. doi: 10.1016/j.mito.2022.02.003. Epub 2022 Feb 24.

Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective

Rossor T, Yeh EA, Khakoo Y, Angelini P, Hemingway C, Irani SR, Schleiermacher G, Santosh P, Lotze T, Dale RC, Deiva K, Hero B, Klein A, de Alarcon P, Gorman MP, Mitchell WG, Lim M; OMS Study Group.

Neurol Neuroimmunol Neuroinflamm. 2022 Mar 8;9(3):e1153. doi: 10.1212/NXI.0000000000001153. Print 2022 May.

Air Pollution and the Risk of Parkinson's Disease: A Review

Murata H, Barnhill LM, Bronstein JM.

Mov Disord. 2022 May;37(5):894-904. doi: 10.1002/mds.28922. Epub 2022 Jan 19.

How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?

Mahlknecht P, Foltynie T, Limousin P, Poewe W.

Mov Disord. 2022 May 12. doi: 10.1002/mds.29052. Online ahead of print.

α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives

Alzghool OM, van Dongen G, van de Giessen E, Schoonmade L, Beaino W.

Mov Disord. 2022 May;37(5):936-948. doi: 10.1002/mds.28984. Epub 2022 Mar 15.

Neuroimaging in Glucocerebrosidase-Associated Parkinsonism: A Systematic Review

Filippi M, Balestrino R, Basaia S, Agosta F.

Mov Disord. 2022 May 6. doi: 10.1002/mds.29047. Online ahead of print.

Finely-tuned gamma oscillations: Spectral characteristics and links to dyskinesia

Wiest C, Torrecillos F, Tinkhauser G, Pogosyan A, Morgante F, Pereira EA, Tan H.

Exp Neurol. 2022 May;351:113999. doi: 10.1016/j.expneurol.2022.113999. Epub 2022 Feb 7.

Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia

Scarduzio M, Hess EJ, Standaert DG, Eskow Jaunarajs KL.

Neurobiol Dis. 2022 May;166:105650. doi: 10.1016/j.nbd.2022.105650. Epub 2022 Feb 6.

Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force - An Update

Lange LM, Gonzalez-Latapi P, Rajalingam R, Tijssen MAJ, Ebrahimi-Fakhari D, Gabbert C, Ganos C, Ghosh R, Kumar KR, Lang AE, Rossi M, van der Veen S, van de Warrenburg B, Warner T, Lohmann K, Klein C,

Mov Disord. 2022 May;37(5):905-935. doi: 10.1002/mds.28982. Epub 2022 Apr 28.

Updates in Functional Movement Disorders: from Pathophysiology to Treatment Advances

Kola S, LaFaver K.

Curr Neurol Neurosci Rep. 2022 May;22(5):305-311. doi: 10.1007/s11910-022-01192-9. Epub 2022 Apr 19.

Movement Disorders and the Gut: A Review

Talman LS, Pfeiffer RF.

Mov Disord Clin Pract. 2022 Feb 5;9(4):418-428. doi: 10.1002/mdc3.13407. eCollection 2022 May.

How to assess eye movements clinically

Froment Tilikete C.

Neurol Sci. 2022 May;43(5):2969-2981. doi: 10.1007/s10072-022-05981-5. Epub 2022 Mar 3.

Movement Disorders in Multiple Sclerosis: An Update

Ghosh R, Roy D, Dubey S, Das S, Benito-León J.

Tremor Other Hyperkinet Mov (N Y). 2022 May 4;12:14. doi: 10.5334/tohm.671. eCollection 2022.

Is there a relationship between the ketogenic diet and sleep disorders?

Barrea L, Pugliese G, Frias-Toral E, Napolitano B, Laudisio D, Aprano S, Ceriani F, Savastano S, Colao A, Muscogiuri G.

Int J Food Sci Nutr. 2022 May;73(3):285-295. doi: 10.1080/09637486.2021.1993154. Epub 2021 Oct 26.

Targeting alpha-synuclein or tau for treating neurodegenerative movement disorders

Lopez-Cuina M, Meissner WG.

Rev Neurol (Paris). 2022 May 10:S0035-3787(22)00571-9. doi: 10.1016/j.neurol.2022.03.010. Online ahead of print.